Published on in Vol 9, No 7 (2020): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16863, first published .
Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study

Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study

Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study

Bridget Louise Draper   1, 2 , BA, BHSc ;   Alisa Pedrana   1, 2 , BBiomedSc, PhD ;   Jessica Howell   1, 3, 4 , MBBS, FRACP, PhD ;   Win Lei Yee   5 , MBBS, MPH ;   Hla Htay   5 , MBBS, MPH ;   Khin Sanda Aung   6 , MBBS, MPH ;   Sonjelle Shilton   7 , MPH ;   Khin Pyone Kyi   8 , MBBS, PhD, MMedSc, FRCP ;   Win Naing   9, 10 , MBBS, FRCP ;   Margaret Hellard   1, 2, 11, 12 , MBBS, PhD

1 Disease Elimination, Burnet Institute, Melbourne, Australia

2 School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

3 Consultant Gastroenterologist, St Vincent's Hospital Melbourne, Melbourne, Australia

4 Department of Medicine, University of Melbourne, Melbourne, Australia

5 Burnet Institute Myanmar, Yangon, Myanmar

6 Myanmar National Hepatitis Control Program, Naypyidaw, Myanmar

7 Foundation for Innovative New Diagnostics, Geneva, Switzerland

8 Myanmar Liver Foundation, Yangon, Myanmar

9 Yangon Specialty Hospital, Yangon, Myanmar

10 University Of Medicine (1), Yangon, Myanmar

11 Department of Infectious Diseases, The Alfred Hospital, Melbourne, Australia

12 Doherty Institute and School of Population and Global Health, University of Melbourne, Melbourne, Australia

Corresponding Author: